Sugi Predict

Sugi Predict / Compounds / SCHEMBL5357974

SCHEMBL5357974

SCHEMBL5357974

COC[C@H]1O[C@@H](n2cnc3c(Cl)ncnc32)[C@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.65
▸ LMNA P02545 1/20 0.65
▸ TP53 P04637 1/20 0.65
▸ MAPT P10636 1/20 0.65
▸ TDP1 Q9NUW8 1/20 0.65
▸ PRKAB2 O43741 1/20 0.54
▸ PRKAG1 P54619 1/20 0.54
▸ PRKAA2 P54646 1/20 0.54
▸ PRKAA1 Q13131 1/20 0.54
▸ PRKAG3 Q9UGI9 1/20 0.54
▸ PRKAG2 Q9UGJ0 1/20 0.54
▸ PRKAB1 Q9Y478 1/20 0.54
▸ ACHE P22303 4/20 0.48
▸ TYMP P19971 1/20 0.47
▸ ADORA3 P0DMS8 4/20 0.45
▸ ADK P55263 1/20 0.44
▸ P2RX3 P56373 2/20 0.44
▸ P2RX4 Q99571 2/20 0.44
▸ P2RX2 Q9UBL9 2/20 0.44
▸ PRMT6 Q96LA8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6667720 1.00 ALDH1A1 (0.65) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL5357965 1.00 ALDH1A1 (0.65) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL14030780 0.92 LMNA (0.77) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL14088746 0.92 LMNA (0.77) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL6887845 0.92 LMNA (0.77) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL3853209 0.92 LMNA (0.77) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL3163131 0.92 LMNA (0.77) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL13264312 0.92 LMNA (0.77) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL10001661 0.92 LMNA (0.77) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL14075781 0.92 LMNA (0.77) ALDH1A1LMNATP53MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189706-B2 C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them UNIVERSITEIT LEIDEN (NL) 2007-03-13 — — US disclosed
US-7084127-B2 C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses UNIVERSITEIT LEIDEN (NL) 2006-08-01 — — US disclosed
US-20040132686-A1 C2,5'- disubstituted and N6, c2,5'- trisubstituted adenosine derivatives and their different uses UNIVERSITEIT LEIDEN (NL) 2004-07-08 — — US disclosed
US-20040127452-A1 C2,5'-disubstituted and N6,C2,5'-trisubstituted adenosine derivatives and pharmaceutical compositions containing them UNIVERSITEIT LEIDEN (NL) 2004-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127452-A1 C2,5'-disubstituted and N6,C2,5'-trisubstituted adenosine derivatives and pharmaceutical compositions containing them ADORA2A, ADORA3, ADORA1 ALDH1A1 1218/4885LMNA 1971/4885TP53 2605/4885
US-20040132686-A1 C2,5'- disubstituted and N6, c2,5'- trisubstituted adenosine derivatives and their different uses ADORA2A, ADORA3, ADORA1 ALDH1A1 1335/4885LMNA 2045/4885TP53 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.